This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Texas Medical Center. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Albertien Greijdanus and a Transcatheter Approach to Interatrial Anastomosis.
Introduction
Albertien Greijdanus is an inventor associated with Houston, Texas, and the Texas Medical Center. His patent work addresses a catheter-based approach to treating heart failure by reducing elevated pressure in the left atrium.
Latest Patents
Greijdanus is credited with 1 patent: “Transcatheter Device for Interatrial Anastomosis.” The patent describes a device assembly and method for creating a sized opening in the interatrial septum, the wall between the heart’s left and right atria. The opening is intended to help relieve elevated left atrial pressure.
The disclosed assembly includes a delivery catheter, a tissue stabilizer, and a cutter. The stabilizer is attached to a catheter with a central lumen and a penetrating tip that allows a guidewire to pass through. The cutter is attached to a second catheter, whose lumen accommodates the first catheter. Alternative configurations may include an additional catheter for access to and from the right atrium, a tissue-retention mechanism, and an optional coaxial alignment mechanism.
Career Highlights
The patent reflects work on a transcatheter technique designed to create an interatrial aperture without relying on open-heart surgery. Its components are arranged to stabilize tissue and guide the cutting process, with the goal of producing an opening of a selected size.
Collaborations
Greijdanus’s listed coworkers include Christopher Alexander Arevalos and Jacob Kriegel. The patent information provided does not specify their individual roles or contributions.
Conclusion
Albertien Greijdanus’s patent describes a catheter-based device for creating an interatrial opening intended to relieve elevated left atrial pressure, highlighting his contribution to an interventional approach to heart failure treatment.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile